ADC-1001

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameADC-1001

Drug Alias Nameinterleukin-1 receptor antagonist (Alligator Bioscience)second generation rheumatoid arthritis therapy (Alligator BioScience)ADC-1001-RAFIND-001ADC-1001 +[6]

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionInterleukin-1 receptor antagonists

TargetsInterleukin-1 receptor

Therapy Area/IndicationsInflammationArthritis, Juvenile

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlligator Bioscience Ab

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlligator Bioscience Ab

Active IndicationsN/A

Inactive IndicationsInflammationArthritis, Juvenile

Other Information

ATC CodeN/A